| First Author | Yoo Y | Year | 2023 |
| Journal | Cell Stem Cell | Volume | 30 |
| Issue | 8 | Pages | 1043-1053.e6 |
| PubMed ID | 37541210 | Mgi Jnum | J:339355 |
| Mgi Id | MGI:7518146 | Doi | 10.1016/j.stem.2023.07.006 |
| Citation | Yoo Y, et al. (2023) A cell therapy approach to restore microglial Trem2 function in a mouse model of Alzheimer's disease. Cell Stem Cell 30(8):1043-1053.e6 |
| abstractText | Alzheimer's disease (AD) remains one of the grand challenges facing human society. Much controversy exists around the complex and multifaceted pathogenesis of this prevalent disease. Given strong human genetic evidence, there is little doubt, however, that microglia play an important role in preventing degeneration of neurons. For example, loss of function of the microglial gene Trem2 renders microglia dysfunctional and causes an early-onset neurodegenerative syndrome, and Trem2 variants are among the strongest genetic risk factors for AD. Thus, restoring microglial function represents a rational therapeutic approach. Here, we show that systemic hematopoietic cell transplantation followed by enhancement of microglia replacement restores microglial function in a Trem2 mutant mouse model of AD. |
